Scleroderma Publications
Most recent publications
Peer-reviewed Publications
- Canizares NV, Pain CE, Zulian F, Adrovic A, Appenzeller S, Marrani E, Del Guidice E, Pettacia A, Tirelli F, Simoni G, Cakan M, Cattalini M, Julio P, Torok K, Khubchandani R, Kasapcopur O, Robinson A, Al-Abadi E, Gunalp A, Lu M, Lythgoe H, Robinson A, Sozeri B, Shenoi S, Williw E, Clarek K, Zheng, R, Castaldi B, Leone V, Manisclaco V, Stead L, Ambatrsumyan L, Rosee F, Duong P, Minuti A, Li SC, Twilt M. Developing consensus outcome measures in juvenile systemic sclerosis: a global survey of pediatric rheumatologists and literature review. Pediatr Rheumatol , 2025
- Foeldvari I, Torok KS, Silva J, Denton CP, Henes J, Horvei P, Rosser F, Orteu CH, Li SC, Pain CE, Constantin T, Costa-Reis P, Curran ML, Cutolo M, Hinrichs B, Fligelstone K, Maillard S, Moinzadeh P, Pilkington C, Schraven L, Smith V. Guidance for stem cell therapy for juvenile systemic sclerosis patients. Expert Rev Clin Immunol. 2025: 435-450. PMID: 40056160.
- Pain CE, Torok KS. Challenges and complications in juvenile localized scleroderma: A practical approach. Best Pract Res Clin Rheumatol. 2024 PMID: 39294014.
- Denton CP, De Lorenzis E, Roblin E, Goldman N, Alcacer-Pitarch B, Blamont E, Buch MH, Carulli M, Cotton C, Del Galdo F, Derrett-Smith E, Douglas K, Farrington S, Fligelstone K, Gompels L, Griffiths B, Herrick A, Hughes M, Pain C, Pantano G, Pauling JD, Prabu A, O'Donoghue N, Renzoni EA, Royle J, Samaranayaka M, Spierings J, Tynan A, Warburton L, Ong VH. The 2024 British Society for Rheumatology guideline for management of systemic sclerosis. Rheumatology (Oxford). 2024:2956-2975. PMID: 39255973.
- Foeldvari I, Torok KS, Antón J, Blakley M, Constantin T, Cutolo M, Denton CP, Fligelstone K, Hinrichs B, Li SC, Maillard S, Marrani E, Moinzadeh P, Orteu CH, Pain CE, Pauling JD, Pilkington C, Rosser F, Smith V, Furst DF. Best clinical practice in the treatment of juvenile systemic sclerosis: expert panel guidance - the result of the International Hamburg Consensus Meeting December 2022. Expert Rev Clin Immunol. 2024 PMID: 38149621.
- Anderson C, Leone V, Pain C. Comment on: Nailfold capillaroscopy: a survey of
current UK practice and 'next steps' to increase uptake among rheumatologists. Rheumatology (Oxford). 2023:e303-e304. PMID: 37527027.
- Pain CE, Murray A, Dinsdale G, Marsden A, Manning J, Riley P, Leone V, Amin T, Zulian F, Herrick AL. Non-invasive imaging and clinical skin scores in juvenile localized scleroderma. Rheumatology (Oxford). 2024:1332-1340. PMID: 37531286.
- Singhal S, Heaf E, Jordan J, Corp N, Pain CE. A Scoping Review of the Efficacy and Safety of Methotrexate Compared to Mycophenolate Mofetil in the Treatment of Juvenile Localized Scleroderma in Children and Young Adults. SN Compr. Clin. Med. 2023:1-17.
- Desai Y, Jaki T, Beresford MW, Burnett T, Eleftheriou D, Jacobe H, Leone V, Li S, Mozgunov P, Ramanan AV, Torok KS, Anderson ME, Anton J, Avcin T, Felton J, Foeldvari I, Laguda B, McErlane F, Shaw L, Zulian F, Pain CE. Prior elicitation of the efficacy and tolerability of Methotrexate and Mycophenolate Mofetil in Juvenile Localised Scleroderma. AMRC Open Res. 2021. PMID: 38708070.
- Lythgoe H, Almeida B, Bennett J, Bhat C, Bilkhu A, Brennan M, Deepak S, Dawson P, Eleftheriou D, Harrison K, Hawley D, Heaf E, Leone V, Long E, Maltby S, McErlane F, Rafiq N, Ramanan AV, Riley P, Rangaraj S, Varnier G, Wilkinson N, Pain CE. Multi-centre national audit of juvenile localised scleroderma: describing current UK practice in disease assessment and management. Pediatr Rheumatol Online J. 2018. PMID: 30563543.
- Constantin T, Foeldvari I, Pain CE, Pálinkás A, Höger P, Moll M, Nemkova D, Weibel L, Laczkovszki M, Clements P, Torok KS. Development of minimum standards of care for juvenile localized scleroderma. Eur J Pediatr. 2018: 961-977. PMID: 29728839.
- Lythgoe H, Baildam E, Beresford MW, Cleary G, McCann LJ, Pain CE. Tocilizumab as a potential therapeutic option for children with severe, refractory juvenile localized scleroderma. Rheumatology (Oxford). 2018: 398-401. PMID: 29077971.